Erowid References Database
Kalasho A, Vibe Nielsen S.
“5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis”.
Acta Anaesthesiol Scand. 2016 Jul 25.
We present a case report in which a patient had ingested an unknown amount of the
drug 5-MeO-DALT, and propose a strategy by which intoxication with the substance can be managed.
A 34-year-old man with no prior medical history was brought to the emergency department by emergency medical services personnel. Details of the circumstances prior to admittance were provided by two of his peers. After having orally ingested an unknown amount of 5-MeO-DALT along with alcohol, the patient had been
lying on the floor for several hours, shouting and exhibiting aggressive behaviour. This was followed by a period of unresponsiveness which prompted the call for an ambulance. Upon arrival at the emergency department (ED) it was clear that the patient was in an altered state of consciousness. Objective findings were as follows:
tachypnea (respiratory frequency of 60) and corresponding signs of hyperventilation on arterial blood gas (ABG); tachycardia (180 beats per minute); blood pressure within normal range; GCS 12; pupils dilated with absent light reflex; temperature elevated to 38.5°C.
[ Cite HTML